These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 25495534)

  • 1. Imaging cytokine targeting to the tumor/bone microenvironment in vivo.
    Ellis J; Falzon M; Emrick T; Figueiredo ML
    Hum Gene Ther Clin Dev; 2014 Dec; 25(4):200-1. PubMed ID: 25495534
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel luciferase fusion protein for highly sensitive optical imaging: from single-cell analysis to in vivo whole-body bioluminescence imaging.
    Mezzanotte L; Blankevoort V; Löwik CW; Kaijzel EL
    Anal Bioanal Chem; 2014 Sep; 406(23):5727-34. PubMed ID: 24958343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive imaging of molecular events with bioluminescent reporter genes in living subjects.
    Ray P; Gambhir SS
    Methods Mol Biol; 2007; 411():131-44. PubMed ID: 18287643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visualizing the location and the dynamics of gene expression in living animals through bioluminescence imaging.
    Chen X
    Methods Cell Biol; 2013; 113():39-49. PubMed ID: 23317896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging mouse cancer models in vivo using reporter transgenes.
    Lyons SK; Patrick PS; Brindle KM
    Cold Spring Harb Protoc; 2013 Aug; 2013(8):685-99. PubMed ID: 23906907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive imaging of firefly luciferase reporter gene expression using bioluminescence imaging in human prostate cancer models.
    Li H; Li JZ; Helm GA; Pan D
    Biotechnol Appl Biochem; 2007 Apr; 46(Pt 4):179-84. PubMed ID: 17073822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive Feedback Loops Between Inflammatory, Bone and Cancer Cells During Metastatic Niche Construction.
    Kianercy A; Pienta KJ
    Adv Exp Med Biol; 2016; 936():137-148. PubMed ID: 27739046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo imaging of cell proliferation for a dynamic, whole body, analysis of undesired drug effects.
    Rizzi N; Manni I; Vantaggiato C; Delledonne GA; Gentileschi MP; Maggi A; Piaggio G; Ciana P
    Toxicol Sci; 2015 Jun; 145(2):296-306. PubMed ID: 25766884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multi-targeted approach to treating bone metastases.
    Camacho DF; Pienta KJ
    Cancer Metastasis Rev; 2014 Sep; 33(2-3):545-53. PubMed ID: 24390423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of bone-associated growth factors and cytokines on the growth of prostate cancer cells derived from soft tissue versus bone metastases in vitro.
    Lee HL; Pienta KJ; Kim WJ; Cooper CR
    Int J Oncol; 2003 Apr; 22(4):921-6. PubMed ID: 12632088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgens and prostate cancer bone metastases: effects on both the seed and the soil.
    Yang W; Levine AC
    Endocrinol Metab Clin North Am; 2011 Sep; 40(3):643-53, x. PubMed ID: 21889726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EZC-prostate models offer high sensitivity and specificity for noninvasive imaging of prostate cancer progression and androgen receptor action.
    Seethammagari MR; Xie X; Greenberg NM; Spencer DM
    Cancer Res; 2006 Jun; 66(12):6199-209. PubMed ID: 16778194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photoactivable bioluminescent probes for imaging luciferase activity.
    Shao Q; Jiang T; Ren G; Cheng Z; Xing B
    Chem Commun (Camb); 2009 Jul; (27):4028-30. PubMed ID: 19568622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tasquinimod inhibits prostate cancer growth in bone through alterations in the bone microenvironment.
    Magnusson LU; Hagberg Thulin M; Plas P; Olsson A; Damber JE; Welén K
    Prostate; 2016 Mar; 76(4):383-93. PubMed ID: 26660725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive bioluminescence imaging of normal and spontaneously transformed prostate tissue in mice.
    Lyons SK; Lim E; Clermont AO; Dusich J; Zhu L; Campbell KD; Coffee RJ; Grass DS; Hunter J; Purchio T; Jenkins D
    Cancer Res; 2006 May; 66(9):4701-7. PubMed ID: 16651422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and validation of improved triple fusion reporter gene vectors for molecular imaging of living subjects.
    Ray P; Tsien R; Gambhir SS
    Cancer Res; 2007 Apr; 67(7):3085-93. PubMed ID: 17409415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly specific expression of luciferase gene in lungs of naïve nude mice directed by prostate-specific antigen promoter.
    Li HW; Li J; Helm GA; Pan D
    Biochem Biophys Res Commun; 2005 Sep; 334(4):1287-91. PubMed ID: 16043123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Firefly luciferase genes from the subfamilies Psilocladinae and Ototretinae (Lampyridae, Coleoptera).
    Oba Y; Yoshida M; Shintani T; Furuhashi M; Inouye S
    Comp Biochem Physiol B Biochem Mol Biol; 2012 Feb; 161(2):110-6. PubMed ID: 22008901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A bioluminogenic substrate for in vivo imaging of beta-lactamase activity.
    Yao H; So MK; Rao J
    Angew Chem Int Ed Engl; 2007; 46(37):7031-4. PubMed ID: 17676567
    [No Abstract]   [Full Text] [Related]  

  • 20. Regarding the article "Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions", by Feeley et al.
    Friedlaender GE
    Bone; 2006 Sep; 39(3):666; author reply 667. PubMed ID: 16774855
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.